CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AMGN's Free Cash Flow Growth by Quarter and Year

Amgen Inc 's Free Cash Flow results by quarter and year




AMGN Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 2,153.00 2,514.00 3,194.00
III Quarter September - 3,368.00 3,377.00 3,273.00
II Quarter June - 2,842.00 1,414.00 2,102.00
I Quarter March 2,104.00 2,134.00 1,845.00 2,727.00
FY   2,104.00 10,497.00 9,150.00 11,296.00



AMGN Free Cash Flow first quarter 2021 Y/Y Growth Comment
Amgen Inc reported decrease in Free Cash Flow in the first quarter by -1.41% to $ 2,104.00 millions, from the same quarter in 2020.
The decrease in the first quarter Amgen Inc 's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow growth of 1.9%.

According to the results reported in the first quarter, Amgen Inc achieved the best Free Cash Flow growth in Biotechnology & Drugs industry. While Amgen Inc ' s Free Cash Flow decline of -1.41% ranks overall at the positon no. 199 in the first quarter.




AMGN Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -14.36 % -21.29 % 6.04 %
III Quarter September - -0.27 % 3.18 % -5.24 %
II Quarter June - 100.99 % -32.73 % -9.63 %
I Quarter March -1.41 % 15.66 % -32.34 % 14.34 %
FY   - 14.72 % -19 % 1.06 %

Financial Statements
Amgen Inc 's first quarter 2021 Free Cash Flow $ 2,104.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2020 Free Cash Flow $ 2,134.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Free Cash Flow Growth >>


AMGN Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - -36.07 % -25.56 % -2.41 %
III Quarter September - 18.51 % 138.83 % 55.71 %
II Quarter June - 33.18 % -23.36 % -22.92 %
I Quarter March -2.28 % -15.12 % -42.24 % -9.46 %
FY (Year on Year)   - 14.72 % -19 % 1.06 %




Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #12
Overall #199

Free Cash Flow Y/Y Growth Statistics
High Average Low
19.9 % 1.9 % -14.5 %
(Sep. 30, 2005)   (June 30. 2013)
Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #12
Overall #199
Free Cash Flow Y/Y Growth Statistics
High Average Low
19.9 % 1.9 % -14.5 %
(Sep. 30, 2005)   (June 30. 2013)

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Amgen Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
5931.25 % 105.43 % -100 %
(June 30. 2004)  


AMGN's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Amgen Inc disclosed fall in Free Cash Flow from the previous quarter by -2.28% to $ 2,104.00 millions, from $ 2,153.00 millions declared in the previous reporting period.

As we analyse current downturn at the I. Quarter, we must assume, that frequently I. Quarter performance appear to be softer relative to the forth quarter, Isla  Taylor, Healthcare sector observer said.

Within Biotechnology & Drugs industry Amgen Inc achieved highest sequential Free Cash Flow growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 82.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #6
Overall #82
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #6
Overall #82
Free Cash Flow Q/Q Growth Statistics
High Average Low
5931.25 % 105.43 % -100 %
(June 30. 2004)  


AMGN's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2021 Amgen Inc disclosed fall in Free Cash Flow from the forth quarter by -2.28% to $ 2,104.00 millions, from $ 2,153.00 millions released a quarter before.

This is not important issue, as I. Quarter Free Cash Flow always seem to slow in this quarter.

Within Biotechnology & Drugs industry Amgen Inc achieved highest sequential Free Cash Flow growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 82.


Amgen Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Free Cash Flow 12 Months Ending $ 11,099.00 $ 11,105.00 $ 11,481.00 $ 11,525.00 $ 10,083.00
Y / Y Free Cash Flow Growth (TTM) 10.08 % 13.69 % 9.5 % 11.01 % -9.27 %
Year on Year Free Cash Flow Growth Overall Ranking # 148 # 196 # 1169 # 321 # 516
Seqeuential Free Cash Flow Change (TTM) -0.05 % -3.27 % -0.38 % 14.3 % 3.22 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 199 # 1570 # 1417 # 178 # 1097




Cumulative Free Cash Flow growth Comment
With the quarterly Free Cash Flow reported in the Mar 31 2021 period, Amgen Inc 's cumulative twelve months Free Cash Flow were $ 11,099 millions, company would post below average annual Free Cash Flow growth of 3.22% year on year, if the fiscal year would end at Mar 31 2021.
A slow-down in the Amgen Inc 's Free Cash Flow growth from the 2153% growth in Dec 31 2020. Despite that, Amgen Inc showed the highest Free Cash Flow growth, among it's peers in Biotechnology & Drugs industry.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 148, from total ranking in previous quarter at 196.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
19.9 %
1.9 %
-14.5 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 1
Healthcare Sector # 13
Overall # 148

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
145.53 %
13.46 %
-18.83 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 12
S&P 500 # 199
Cumulative Free Cash Flow growth Comment
With the quarterly Free Cash Flow reported in the Mar 31 2021 period, Amgen Inc 's cumulative twelve months Free Cash Flow were $ 11,099 millions, company would post below average annual Free Cash Flow growth of -18.83% year on year, if the fiscal year would end at Mar 31 2021.
A slow-down in the Amgen Inc 's Free Cash Flow growth from the 2153% growth in Dec 31 2020. Despite that, Amgen Inc showed the highest Free Cash Flow growth, among it's peers in Biotechnology & Drugs industry.

Among companies within the Healthcare sector 12 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 148, from total ranking in previous quarter at 196.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
19.9 %
1.9 %
-14.5 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 1
Healthcare Sector # 13
Overall # 148

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
145.53 %
13.46 %
-18.83 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 12
S&P 500 # 199




Other Free Cash Flow Growth
Biotechnology & Drugs Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
AMGN's Free Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for AMGN's Competitors
Free Cash Flow Growth for Amgen Inc 's Suppliers
Free Cash Flow Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Free Cash Flow fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2021
Option Care Health Inc -0.12%$ -0.125 millions
Amgen Inc -1.41%$ -1.406 millions
Bristol Myers Squibb Co-1.80%$ -1.798 millions
Zoetis Inc -1.96%$ -1.961 millions
Utah Medical Products Inc-2.49%$ -2.485 millions
Repligen Corp-2.81%$ -2.812 millions
Regeneron Pharmaceuticals Inc -4.23%$ -4.226 millions
Lifevantage Corp-4.76%$ -4.763 millions
Electromed Inc -6.16%$ -6.160 millions
American Shared Hospital Services-17.88%$ -17.881 millions
Resmed Inc -18.11%$ -18.113 millions
Iradimed Corp-21.19%$ -21.189 millions
Stryker Corp-23.52%$ -23.519 millions
Corcept Therapeutics Inc-23.59%$ -23.587 millions
Adapthealth Corp -24.61%$ -24.611 millions
Henry Schein Inc -30.00%$ -30.002 millions
Radnet Inc -31.36%$ -31.357 millions
Ligand Pharmaceuticals Incorporated-36.45%$ -36.450 millions
Diversified Healthcare Trust-38.16%$ -38.162 millions
Phibro Animal Health Corp-38.31%$ -38.312 millions
Catalent Inc -38.37%$ -38.373 millions
Atrion Corporation-42.30%$ -42.296 millions
Zimmer Biomet Holdings Inc -45.33%$ -45.332 millions
Catalyst Pharmaceuticals Inc -47.12%$ -47.124 millions
Biogen Inc -47.59%$ -47.591 millions
Avantor Inc -49.86%$ -49.862 millions
Tivity Health Inc -51.90%$ -51.900 millions
Integrated Biopharma Inc-52.87%$ -52.870 millions
Davita Inc -57.18%$ -57.183 millions
United Therapeutics Corporation-58.15%$ -58.155 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VERU's Profile

Stock Price

VERU's Financials

Business Description

Fundamentals

Charts & Quotes

VERU's News

Suppliers

VERU's Competitors

Customers & Markets

Economic Indicators

VERU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071